Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective

被引:5
|
作者
Setyawan, Juliana [1 ]
Fridman, Moshe [2 ]
Hodgkins, Paul [1 ]
Quintero, Javier [3 ]
Erder, M. Haim [1 ]
Katic, Bozena J. [1 ]
Harpin, Valerie [4 ]
机构
[1] Shire, 725 Chesterbrook Blvd, Wayne, PA 19087 USA
[2] AMF Consulting Inc, Los Angeles, CA USA
[3] Hosp Univ Infanta Leonor, Madrid, Spain
[4] Ryegate Childrens Ctr, Sheffield, S Yorkshire, England
关键词
ADHD; Children and adolescents; Treatment outcomes; Treatment satisfaction; Symptom impairment; Comorbidities;
D O I
10.1007/s12402-014-0143-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We evaluated the association between those symptoms/behaviours of attention-deficit/hyperactivity disorder (ADHD) that were present at diagnosis and outcomes of treatment in children and adolescents in six European countries. Physicians abstracted clinical records from patients (6-17 years) diagnosed with ADHD between 2004 and 2007 and treated for >= 2 years. Physicians scored the severity of impairment for core ADHD symptoms and additional (non-core) ADHD symptoms/behaviours at diagnosis and estimated treatment adherence (defined as an estimated >80 % adherence on weekdays and >50 % adherence on weekends). Treatment modalities included pharmacological treatment, behavioural therapy, or both. Pharmacological treatment was further subclassified by medication class. The outcome, optimal treatment success (OTS), was defined as complete symptom control with high satisfaction with treatment. Multivariate logistic regression modelling examined the relationship between OTS and symptom impairment. Of 730 patients, 200 (27 %) achieved OTS. These patients were more likely to demonstrate lower impairment in non-core ADHD symptoms/behaviours and have fewer pre-existing comorbidities. They were also more likely to be adherent and engaged with treatment, with an explicit treatment goal to improve inattention/school performance. Neither core symptoms' severity nor treatment types were associated with OTS. OTS rates were low, with patients having less impairment of non-core ADHD symptoms/behaviours and fewer comorbidities more likely to achieve OTS. Potentially modifiable factors affecting OTS were as follows: treatment adherence, treatment engagement, and a treatment goal to improve inattention/school performance. These data suggest that there may be opportunities to optimize current treatment use, and develop new treatment strategies to improve core and non-core ADHD symptoms/behaviours.
引用
收藏
页码:75 / 87
页数:13
相关论文
共 50 条
  • [21] Attention-deficit/hyperactivity Disorder and Suicidality in Children and Adolescents
    Balazs, J.
    Miklosi, M.
    Kereszteny, A.
    Dallos, G.
    Gadoros, J.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [22] Managing Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    McClain, Elizabeth K.
    Burks, Erin Jewell
    PRIMARY CARE, 2015, 42 (01): : 99 - +
  • [23] ATTENTION-DEFICIT HYPERACTIVITY DISORDER - AIDS IN CHILDREN AND ADOLESCENTS
    ALGER, I
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1989, 40 (12): : 1222 - 1223
  • [24] Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Storebo, Ole J.
    Simonsen, Erik
    Gluud, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18): : 2009 - 2010
  • [25] Relationship Between Amphetamine Concentrations in Saliva and Serum in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Wohkittel, Christopher
    Hogger, Petra
    Fekete, Stefanie
    Romanos, Marcel
    Gerlach, Manfred
    THERAPEUTIC DRUG MONITORING, 2021, 43 (04) : 564 - 569
  • [26] Stimulant medication and symptom interrelations in children, adolescents and adults with attention-deficit/hyperactivity disorder
    van der Pal, Zarah
    Geurts, Hilde M.
    Haslbeck, Jonas M. B.
    van Keeken, Alex
    Bruijn, Anne Marijn
    Douw, Linda
    van Rooij, Daan
    Franke, Barbara
    Buitelaar, Jan
    Lambregts-Rommelse, Nanda
    Hartman, Catharina
    Oosterlaan, Jaap
    Luman, Marjolein
    Reneman, Liesbeth
    Hoekstra, Pieter J.
    Blanken, Tessa F.
    Schrantee, Anouk
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024,
  • [27] Treatment Needs of Children with Attention-deficit/hyperactivity disorder Beyond Symptom Control
    Agarwal, Vivek
    Dhanasekaran, Saranya
    JOURNAL OF INDIAN ASSOCIATION FOR CHILD AND ADOLESCENT MENTAL HEALTH, 2013, 9 (01): : 1 - 4
  • [28] Atomoxetine Treatment in Adolescents with Attention-Deficit/Hyperactivity Disorder
    Wietecha, Linda A.
    Williams, David W.
    Herbert, Michael
    Melmed, Raun D.
    Greenbaum, Michael
    Schuh, Kory
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (06) : 719 - 730
  • [29] Attention-deficit/hyperactivity disorder in adolescents
    Robin, AL
    PEDIATRIC ANNALS, 2002, 31 (08): : 485 - 491
  • [30] ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADOLESCENTS
    BIEDERMAN, J
    STEINGARD, R
    PSYCHIATRIC ANNALS, 1989, 19 (11) : 587 - 596